[HTML][HTML] Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6. 2 mutations
…, I Flechtner, PR Njølstad, MT Malecki… - … England Journal of …, 2006 - Mass Medical Soc
Background Heterozygous activating mutations in KCNJ11, encoding the Kir6.2 subunit of
the ATP-sensitive potassium (K ATP ) channel, cause 30 to 58 percent of cases of diabetes …
the ATP-sensitive potassium (K ATP ) channel, cause 30 to 58 percent of cases of diabetes …
Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus
The helix-loop-helix (HLH) protein NEUROD1 (also known as BETA2) functions as a
regulatory switch for endocrine pancreatic development. In mice homozygous for a targeted …
regulatory switch for endocrine pancreatic development. In mice homozygous for a targeted …
Genetics of type 2 diabetes mellitus
MT Malecki - Diabetes research and clinical practice, 2005 - Elsevier
The clinical picture of type 2 diabetes mellitus (T2DM) is formed by impairment in insulin
secretion and resistance to insulin action. As a result of intensive efforts of the scientists around …
secretion and resistance to insulin action. As a result of intensive efforts of the scientists around …
[HTML][HTML] Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study
Background KCNJ11 mutations cause permanent neonatal diabetes through pancreatic
ATP-sensitive potassium channel activation. 90% of patients successfully transfer from insulin to …
ATP-sensitive potassium channel activation. 90% of patients successfully transfer from insulin to …
[HTML][HTML] Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed …
…, G Niesyczyński, J Lis, A Syta, MT Malecki - Acta …, 2015 - Springer
Aims A variety of basal insulin preparations are used to treat patients with type 2 diabetes
mellitus (T2DM). We aimed to summarize scientific evidence on relative efficacy and safety of …
mellitus (T2DM). We aimed to summarize scientific evidence on relative efficacy and safety of …
[HTML][HTML] miR-375 gene dosage in pancreatic β-cells: implications for regulation of β-cell mass and biomarker development
MicroRNAs play a crucial role in the regulation of cell growth and differentiation. Mice with
genetic deletion of miR-375 exhibit impaired glycemic control due to decreased β-cell and …
genetic deletion of miR-375 exhibit impaired glycemic control due to decreased β-cell and …
Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11
…, J Kusmierek, T Klupa, MT Malecki… - Nature clinical practice …, 2007 - nature.com
Background A 12-week-old female presented with neonatal diabetes. Insulin therapy alleviated
the diabetes, but the patient showed marked motor and mental developmental delay. …
the diabetes, but the patient showed marked motor and mental developmental delay. …
[PDF][PDF] Characteristics of gut microbiota in adult patients with type 1 and type 2 diabetes based on next-generation sequencing of the 16S rRNA gene fragment
…, M Bulanda, T Klupa, MT Małecki, T Gosiewski - Pol Arch Intern …, 2018 - researchgate.net
INTRODUCTION Scientific data indicate a possible influence of gut microbiota on the
development of type 1 and type 2 diabetes mellitus (T1DM and T2DM, respectively). Sequence …
development of type 1 and type 2 diabetes mellitus (T1DM and T2DM, respectively). Sequence …
Negative pressure wound therapy use in diabetic foot syndrome—from mechanisms of action to clinical practice
…, C Frankfurter, B Kiec‐Wilk, MT Malecki - European Journal of …, 2019 - Wiley Online Library
Background Diabetes and its complications constitute a rising medical challenge. Special
attention should be given to diabetic foot syndrome (DFS) due to its high rate of associated …
attention should be given to diabetic foot syndrome (DFS) due to its high rate of associated …
[HTML][HTML] Quantitative evaluation of fungi of the genus Candida in the feces of adult patients with type 1 and 2 diabetes - a pilot study
…, D Salamon, M Szopa, A Sroka, MT Malecki… - Gut Pathogens, 2014 - Springer
Background Gastrointestinal tract microbiota, particularly bacterial microflora, seem to have a
different qualitative and quantitative composition in both type 1 (T1DM) and type 2 diabetes …
different qualitative and quantitative composition in both type 1 (T1DM) and type 2 diabetes …